跳至主要内容
临床试验/NL-OMON29078
NL-OMON29078尚未招募不适用

Effect of Reslizumab on small airways in asthma - RESSAPEA

Amsterdam University Medical Centre, University of Amsterdam0 个研究点目标入组 33 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients will be aged 18 - 75 years and have a confirmed diagnosis of severe eosinophilic asthma according to ERS/ATS guidelines. All patients will show persistent blood eosinophilia of >0.4 x 10E9/L despite treatment with high doses of inhaled corticosteroids (>1000 ug/day fluticasone equivalent), or >0.15 x 10E9/L despite chronic oral corticosteroid treatment

排除标准

  • Current smokers or former smokers with a smoking history of ≥15 pack years. A former smoker is defined as a subject who quit smoking at least 6 months prior to Visit 1
  • Chronic pulmonary disorders other than asthma

研究者

发起方
Amsterdam University Medical Centre, University of Amsterdam

相似试验